Profil
Reena L.
Pande currently works at AbleTo, Inc., as Chief Medical Officer from 2013 and Oxeon Investments LLC, as Partner from 2024.
Dr. Pande received her graduate degree from Harvard T.H.
Chan School of Public Health, undergraduate degree in 1996 from Harvard University, and doctorate degree in 2001 from Harvard Medical School.
Aktive Positionen von Reena L. Pande
| Unternehmen | Position | Beginn |
|---|---|---|
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2013 |
Oxeon Investments LLC
Oxeon Investments LLC Investment ManagersFinance Oxeon Investments invests in companies located in the United States. The firm focuses on the healthcare sectors and services. It participates in seed and early stage capital transactions. | Private Equity Investor | 01.10.2024 |
Ausbildung von Reena L. Pande
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxeon Investments LLC
Oxeon Investments LLC Investment ManagersFinance Oxeon Investments invests in companies located in the United States. The firm focuses on the healthcare sectors and services. It participates in seed and early stage capital transactions. | Finance |
















